Nymirum
Pioneering the future of RNA-targeted therapies through precision-driven 3D structure solutions
General Information
BounceWatch is an independent company data service, not affiliated with Nymirum. To contact Nymirum, visit nymirum.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Nymirum compare?
A PDF of Nymirum and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Nymirum soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Nymirum
Business keywords: RNA-targeted therapies, 3D structure solutions, RNArchitect suite, proprietary drug discovery platform, small molecules, biotech, precision medicine, precision-driven, venture-backed, private company
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $2.79M | 2 |
|
01 Jan 2010 |
| Seed Round | $550.00K | 1 |
|
22 May 2009 |
Nymirum Alternatives & Competitors
View All Alternatives
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions o...
Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse disease states.
Bringing transformative therapies to patients with severe RNA-mediated diseases.
FAQ About Nymirum
Source: BounceWatch company record for Nymirum, https://bouncewatch.com/company/nymirum, updated 12 September 2024. When citing, please name BounceWatch and link this page.
